HPV Vaccine
11 Sept 2026 · 3 min read

On this page6 sections
The HPV vaccine significantly reduces your chances of contracting the human papillomavirus (HPV). HPV is an exceptionally common virus that spreads easily through direct skin-to-skin contact, most frequently during sexual activity.
While the majority of HPV strains are entirely harmless and clear naturally, certain high-risk strains are directly linked to an increased risk of developing specific cancers. These include cervical, mouth and throat (oropharynx), anal, penile, vulval, and vaginal cancers. HPV can also cause genital warts.
1. Who Should Get the Vaccine?
School-Aged Children: The HPV vaccine is highly recommended for all boys and girls in their first year of secondary school. It is administered entirely free of charge through the HSE School Vaccination Programme.
Catch-Up & Immuno-compromised Individuals: The vaccine is also recommended for students who missed their scheduled dose in the first year of secondary school, as well as individuals living with a weakened immune system or specific chronic medical conditions.
2. Who Should Not Get the Vaccine?
Medical exclusions for the HPV vaccine are rare. You should not receive the vaccine if you:
Are currently pregnant (the vaccine is not recommended during pregnancy).
Have a history of a severe allergic reaction (anaphylaxis) to a previous dose of the HPV vaccine.
Have a known life-threatening allergy to any of the specific ingredients contained within the vaccine.
3. Vaccine Brand, Safety, and Quality Control
The standard vaccine utilized in Ireland is Gardasil 9, which provides targeted protection against 9 distinct strains of HPV, including those most likely to cause malignant cancers.
The vaccine maintains an excellent, globally verified safety record and is standard in national immunisation frameworks worldwide. Safety profiles and batch quality are continuously monitored by the Health Products Regulatory Authority (HPRA) and the European Medicines Agency (EMA).
For an exhaustive list of excipients, components, and chemical formulations, consult the manufacturer's Patient Information Leaflet online.
4. Common and Rare Side Effects
Like any immunisation, the HPV vaccine can cause side effects. The vast majority of these symptoms are mild, transient, and resolve independently within 1 to 2 days.
Very Common: Localized redness, swelling, or pain at the physical injection site.
Systemic Symptoms: Headaches, a temperature of 38°C or higher, dizziness, nausea, or temporary fatigue.
Rare Events: Fainting can occasionally occur post-injection. Severe allergic reactions are exceptionally rare; clinical vaccination teams are fully trained to recognize anaphylaxis and administer immediate emergency treatment on site.
Management: If your child experiences localized discomfort or a low-grade fever, you can administer paracetamol or ibuprofen following the packaging instructions.
🚨 Urgent Advice: If you are deeply concerned about your child's physical symptoms following their vaccination, immediately contact your local school vaccination team, your GP, an out-of-hours medical service, or your nearest hospital Emergency Department (ED).
5. Critical Note on Cervical Screening
While the vaccine provides powerful protection against the most dangerous high-risk strains, it does not protect against all types of HPV. For this reason, individuals with a cervix must continue to attend all scheduled cervical screening appointments (smear tests) when invited. Routine screening remains essential because it can detect active cellular changes or alternative strains not covered by the baseline vaccine.
Disclaimer
The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.
